Model Medicines uses human expertise and AI to accelerate the development of life-changing drugs at scale.
Model Medicines uses human expertise and AI to accelerate the development of life-changing drugs at scale. Model Medicines harnesses AI and ML with its ActivPred AI Drug Discovery Platform to discover drugs that may be repositioned to serve as therapeutics to treat patients suffering from humankind’s toughest diseases.The drugs that Model Medicines discovers can enter clinical trials in as little as several months.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 1, 2021 | Seed | $4.10M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Particle Accelerator Limited (ParticleX) | — | Seed |